Immuneering Corp. (IMRX)
5.15
+0.03
(+0.59%)
USD |
NASDAQ |
Mar 24, 10:57
Immuneering Shareholders Equity (Quarterly) : 218.48M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 327.19M |
| Verastem, Inc. | 57.20M |
| Phathom Pharmaceuticals, Inc. | -438.17M |
| Tango Therapeutics, Inc. | 346.18M |
| X4 Pharmaceuticals, Inc. | 186.29M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 231.98M |
| Total Liabilities (Quarterly) | 13.50M |
| Debt to Equity Ratio | 0.0175 |
| Current Ratio | 17.50 |
| Net Debt Paydown Yield | 0.02% |